Backed by Scale.
Built on Trust.
Supporting Science Where It Happens
ANTISEL provides advanced equipment and solutions for the scientific, diagnostic, and industrial markets, supported by expert teams and trusted global partners.
Explore More
Health Institutions & Professionals
Empowering hospitals, clinics, labs, and healthcare professionals with advanced technologies, reliable equipment, and expert support to improve outcomes and ensure precision in patient care.
Production & Quality Control
Supporting industrial and regulated environments with precise analytical tools, validated workflows, and compliance-ready service that ensures quality, safety, and performance at scale.
Laboratories & Academia
Enabling academic institutions and research labs with high-performance instruments, application expertise, and scalable solutions that fuel education, experimentation, and discovery.
Solutions Aligned with Your Scientific Field
Scientific Research & Applications
Supporting discovery from bench to bedside, through solutions for genomics, proteomics, cell biology, and translational research.
Clinical Diagnostics
Reliable diagnostic technologies and expert support for clinical laboratories, hospitals, and healthcare providers.
Applied Science
Transforming applied sciences with solutions for safer food, better medicines, and smarter materials.
Analytical Sciences
Delivering high-end analytical solutions that advance research, discovery, and scientific progress.
More than Service – A Commitment
Installation & Validation
Certified setup that ensures accuracy, compliance, and immediate readiness.
Training & Support
Hands-on guidance that builds confidence and maximizes lab performance.
Preventive Maintenance
Scheduled care that reduces downtime and extends equipment life.
Emergency Repairs
Fast, reliable fixes, on-site or remote, to keep your work uninterrupted.
Warranty & Service Plans
Flexible contracts for long-term reliability.
Performance Monitoring & Upgrades
Stay current and compliant.
News & Events
Explore insights, technology updates, and past and upcoming scientific events from ANTISEL.
Visit BlogANTISEL participates in GRAPE_ANTHO: Research and innovation for the valorization of winery by-products
ANTISEL S.A. participates in the research and innovation project “Utilization of anthocyanin extracts from vinification waste”, with the acronym GRAPE_ANTHO.
Molecular diagnostics in oncology: Eliminating barriers for tumor profiling
Εxplore molecular diagnostics in oncology through ANTISEL’s satellite lecture on tumor profiling, NGS workflows, Genexus and precision medicine.
ANTISEL and the Entropy UoWM Chem-E-Car Award: Supporting the next generation of chemical engineers
ANTISEL proudly supported Entropy UoWM, who won the bronze medal at a Chem-e-Car, helping young researchers turn scientific ideas into reality.
Oncomine Grant Program: New funding opportunity for clinical research
ANTISEL is pleased to share the launch of Thermo Fisher Scientific's Ion Torrent™ Oncomine™ Clinical Research Grant Program 2026, an important funding opportunity in the fields of oncology and precision medicine.
National Cancer Plan for Greece: Diagnostic infrastructure and technological readiness
The National Cancer Plan for Greece establishes a framework to improve oncology care in Greece. Its effective implementation, however, hinges on the operational readiness of diagnostic units and their ability to consistently meet heightened demands.
ANTISEL has been appointed as the authorized distributor of PerkinElmer in Cyprus
Our presence in Cyprus now reflects a comprehensive portfolio aligned with globally recognized manufacturers, including SCIEX, ZEISS, Sartorius, and PerkinElmer.
Oncomine™ Comprehensive Assay Plus: Complete CGP test, now on the Genexus™ system
Comprehensive Genomic Profiling (CGP) is at the heart of personalized medicine, enabling the identification of multiple genomic alterations in a single test. The Oncomine™ Comprehensive Assay Plus, powered by Ion Torrent™ technology, provides a streamlined approach to CGP, covering 517 unique genes across key cancer-related biomarkers.